Jan 2024 $81 M No. 5 $50 to $250 million 30
ExploraMed NC7, Inc.: Raise no. 5, Jan 2024 × Investors in this round 30 investors had bought by the notice of Jan 22, 2024: 30 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $81 M of $107 M offered; $26 M still to sell
Smallest investment taken no minimum stated
What was sold equity, options or other rights to buy securities, securities to be acquired by exercising them Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Kelly Kennedy · Executive Officer Sarah O'Leary · Executive Officer, Director Scott Becker · Executive Officer Addison Wright · Director Avinash Amin · Director Michael Carusi · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Sarah O'Leary, Chief Executive Officer and Director. Source: SEC Form D, newest notice filed Jan 22, 2024. Read the notice at the SEC .
equity, options SEC Sep 2020 $33 M No. 4 $10 to $50 million 35
ExploraMed NC7, Inc.: Raise no. 4, Sep 2020 × Investors in this round 35 investors had bought by the notice of Oct 1, 2020: 35 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $33 M of $45 M offered; $13 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew W Chmyz · Executive Officer Laura Chambers · Executive Officer, Director Ivy W Ross · Director Joshua Makower · Director Michael Carusi · Director Nina W Richardson · Director Robert W Croce · Director Stacy W Feld · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Andrew Chmyz, Chief Financial Officer. Source: SEC Form D, newest notice filed Oct 1, 2020. Read the notice at the SEC .
equity SEC Jul 2019 $23 M No. 3 $10 to $50 million 7
ExploraMed NC7, Inc.: Raise no. 3, Jul 2019 × Investors in this round 7 investors had bought by the notice of Aug 15, 2019: 7 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $23 M of $29 M offered; $7 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew W. Chmyz · Executive Officer Naomi Kelman · Executive Officer, Director Ivy W. Ross · Director Joshua W. Makower · Director Michael Carusi · Director Nina W. Richardson · Director Robert W. Croce · Director Stacy W. Feld · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Naomi Kelman, President & CEO. Source: SEC Form D, newest notice filed Aug 15, 2019. Read the notice at the SEC .
equity SEC Nov 2017 $27 M No. 2 $10 to $50 million 12
ExploraMed NC7, Inc.: Raise no. 2, Nov 2017 × Investors in this round 12 investors had bought by the notice of Dec 12, 2017: 12 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $27 M of $31 M offered; $4 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Andrew W. Chmyz · Executive Officer Naomi G. Kelman · Executive Officer, Director Ivy W. Ross · Director Joshua W. Makower · Director Michael K. Carusi · Director Nina W. Richardson · Director Robert K. Anderson · Director Robert W. Croce · Director Stacy W. Feld · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Andrew Chmyz, Chief Financial Officer. Source: SEC Form D, newest notice filed Dec 12, 2017. Read the notice at the SEC .
equity SEC Jan 2015 $17 M No. 1 $10 to $50 million 43
ExploraMed NC7, Inc.: Raise no. 1, Jan 2015 × Investors in this round 43 investors had bought by the notice of Mar 9, 2015: 43 accredited, none not accredited.
Names not published. The SEC notice gives only the number of investors, and no official source we use names who bought in this round.
What the notice says
Amount sold $17 M of $18 M offered; $0 M still to sell
Smallest investment taken $1
What was sold equity Exemption claimed Rule 506(b): a private sale without public advertising; up to 35 buyers may be non-accredited
Meant to last a year or less
Issuer's revenue Not disclosed
Sales commissions none
Finders' fees none
Paid to its own people none (proceeds used for payments to executives, directors or promoters)
The company Corporation, incorporated in Delaware People named in the notice Naomi Kelman · Executive Officer, Director Joshua Makower · Director Michael Carusi · Director Michael Chuisano · Director Robert Anderson · Director Robert Croce · Director Ryan Drant · Director Executive officers, directors and promoters, as the form asks. Directors of a funded startup are often partners of its investors.
Paid to sell the round No one: the notice names no broker or finder paid to sell it.
Signed by Naomi Kelman, President/CEO. Source: SEC Form D and 1 amendment, newest notice filed Mar 9, 2015. Read the notice at the SEC .
equity SEC